In TNM stages, CYR61 positive staining is observed in 53% of stage III/IV patients who had distant site metastasis or severe lymph node metastasis, compared to 30% of stage I/II who had no or minor lymph node metastasis. The gene discussed is CCN1; the disease is metastatic malignant neoplasm in the lymph nodes.